Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

TSXV:TELO - Post by User

Telo Genomics Corp

<< Previous

Bullboard Posts

Next >>

Post by bandi10on Dec 08, 2020 1:37am

146 Views

Post# 32055915

shorts

V : TELO	2020-11-30	13,100	-112,900	46,685,323	0.03
V : TELO	2020-11-15	126,000	126,000	41,988,323	0.30
V : TELO	2020-10-15	1,000	570	41,988,323	0.00
V : TELO	2020-09-30	430	430	41,988,323	0.00
V : TELO	2020-08-31	2,000	1,876	41,396,053	0.00